title: Cooperative relationship between pharmaceutical companies, academia, and media explains sharp decrease in frequency of pulmonary complications after bortezomib in Japan.
authors.forename: Hiroto
authors.initials: H
authors.lastname: Narimatsu
authors.forename: Akiko
authors.initials: A
authors.lastname: Hori
authors.forename: Tomoko
authors.initials: T
authors.lastname: Matsumura
authors.forename: Yuko
authors.initials: Y
authors.lastname: Kodama
authors.forename: Morihito
authors.initials: M
authors.lastname: Takita
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Kishi
authors.forename: Tamae
authors.initials: T
authors.lastname: Hamaki
authors.forename: Koichiro
authors.initials: K
authors.lastname: Yuji
authors.forename: Yuji
authors.initials: Y
authors.lastname: Tanaka
authors.forename: Tsunehiko
authors.initials: T
authors.lastname: Komatsu
authors.forename: Masahiro
authors.initials: M
authors.lastname: Kami
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D002986:Clinical Trials as Topic; D003299:Cooperative Behavior; D004345:Drug Industry; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D033183:Interdisciplinary Communication; D020407:Internet; D007564:Japan; D008171:Lung Diseases / Q000139:chemically induced / Q000517:prevention & control*; D008402:Mass Media; D008503:Medical Staff; D009101:Multiple Myeloma / Q000188:drug therapy*; D009524:Newspapers as Topic; D018579:Patient Selection; D010506:Periodicals as Topic; D017410:Practice Guidelines as Topic; D011719:Pyrazines / Q000009:adverse effects*; D018570:Risk Assessment; D012955:Societies, Medical
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib